Phil - About the company
Phil is a series D company based in San Francisco (United States), founded in 2015. It operates as a Technology-driven hub simplifying medication access and improving patient outcomes. Phil has raised $100M in funding from investors like Crosslink Capital, Warburg Pincus and GreatPoint Ventures. The company has 4660 active competitors, including 373 funded and 196 that have exited. Its top competitors include companies like Innovaccer, Veeva Systems and Omnicell.
Company Details
Technology-driven hub simplifying medication access and improving patient outcomes. They offer solutions to pharmaceutical manufacturers, patients, and providers, streamlining the prescription journey. Their platform focuses on maximizing patient access and adherence through a direct-to-patient approach. They provide a comprehensive solution for commercial success, leveraging a digital hub and technology to improve patient experience and drive brand performance. They offer advanced prior authorization processes, an integrated pharmacy network, and end-to-end visibility with data and insights. Their services include patient login, book demo, and a commitment to improving lives through technology. They are a B2B and B2C company offering SaaS and software solutions. They aim to create a social impact by improving patient health outcomes.
- Website
- phil.us
- Email ID
- *****@phil.us
- Phone Number
- +1 **********
- Registered Address
- San Francisco, California
Key Metrics
Founded Year
2015
Location
San Francisco, United States
Stage
Series D
Total Funding
$100M in 7 rounds
Latest Funding Round
Investors
Ranked
67th among 4660 active competitors
Employee Count
293 as on Sep 30, 2026
Legal entities associated with Phil
Phil is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PHIL, INC. CIN: 32092664914 , United States, Active | Nov 29, 2023 | - | - | - |
PHIL INC. CIN: 474554128 , United States, Active | Dec 31, 1999 | - | 227 (As on Dec 31, 2024) | - |
Sign up to download Phil's company profile
Phil's funding and investors
Phil has raised a total funding of $100M over 7 rounds. Its first funding round was on Aug 13, 2015. Its latest funding round was a Venture Debt round on Jul 08, 2025 for $*****. 1 investor participated in its latest round. Phil has 17 institutional investors.
Here is the list of recent funding rounds of Phil:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 08, 2025 | 5427003 | Venture Debt | 7552058 | 5345665 | 4686858 | 4137374 |
Jun 03, 2021 | 2238920 | Series D | 3954423 | 4394244 | 2136851 | 2261264 |
May 15, 2019 | 6673104 | Series B | 7734863 | 2573025 |
Access funding benchmarks and valuations. Sign up today!View details of Phil's funding rounds and investors
Phil's founders and board of directors
Founder? Claim ProfilePhil's Board of Directors
Phil's board has 1 active member. Deepak Thomas is independent board member.Here is the list of Phil's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 11y 1m |
Phil's employee count trend
Phil has 293 employees as of Sep 26. Here is Phil's employee count trend over the years:
Uncover Phil's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Phil's Competitors and alternates
Top competitors of Phil include Innovaccer, Veeva Systems and Omnicell. Here is the list of Top 10 competitors of Phil, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Innovaccer 2014, San Francisco (United States), Series F | Developer of healthcare data platforms and artificial intelligence agent software | $675M | 78/100 | |
2nd | Veeva Systems 2007, Pleasanton (United States), Public | Cloud-based administrative data management solution for the healthcare sector | $4M | 76/100 | |
3rd | Omnicell 1992, Mountain View (United States), Public | Developer of automated dispensing system for pharmacies | $20M | 76/100 | |
4th | NimbleRx 2015, Palo Alto (United States), Acquired | Provider of digital pharmacy management software and prescription delivery services | $74.7M | 75/100 | |
5th | _1584015723684.png?devicePixelRatio=2&height=30&width=30){kind=logo} Alto 2015, San Francisco (United States), Acquired | Online pharmacy offering prescription delivery services | $592M | 75/100 | |
6th |  Blink Health 2015, New York City (United States), Series B | Online pharmacy offering discounted prescription drugs | $165M | 75/100 | |
7th | Online pharmacy providing pharmacy products and healthcare services | $88.3M | 74/100 | ||
8th | SastaSundar 2011, Kolkata (India), Acquired | Provider of an online marketplace for health care products | $48.2M | 74/100 | |
9th | Pharmacy2U 1999, Leeds (United Kingdom), Series C | Online pharmacy and teleconsultation platform | $313M | 74/100 | |
10th |  IKS Health 2006, Navi Mumbai (India), Public | Provider of healthcare technology and services for revenue cycle management and clinical support | $9.35M | 74/100 | |
67th |  Phil 2015, San Francisco (United States), Series D | Technology-driven hub simplifying medication access and improving patient outcomes | $100M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Phil's competitors? Click here to see the top ones
Phil's Investments and acquisitions
Phil has made no investments or acquisitions yet.
Reports related to Phil
Here is the latest report on Phil's sector:
News related to Phil
Filter this listMedia has covered Phil for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
PHIL Partners with Biotechnology Leader, Evolved Health, to Launch New Day™ Skin Spray Direct-to-Patient ProgramBusiness Wire•Sep 01, 2026•Phil
•
PHIL Launches Direct-to-Patient 2.0 Platform to Transform Pharma AccessBusiness Wire•Sep 22, 2025•Phil
•
Phil Receives $60 Million Debt Financing from K2 HealthVenturessvdaily.com•Jul 14, 2025•K2 HealthVentures, Phil
•
Phil scores $60M in growth debt financing and more digital health fundingMobiHealthNews•Jul 10, 2025•K2 HealthVentures, Phil
•
Phil Cline Family YMCA hopes to raise $4M in five years for new soccer fields, gymHerald Dispatch•Feb 15, 2025•Phil
•
•
Phil and RedHill Biopharma Partner to Increase Access to Talicia®Business Wire•Jul 06, 2023•Phil, RedHill Biopharma
•
•
Phil Inc. Adds Duchesnay USA’s Women’s Healthcare Product to Its Patient Access PlatformTullahoma News•Jan 09, 2023•Phil
•
ScriptDrop and Phil Partner to Remove Barriers to Prescription AccessNewswire•Nov 29, 2022•Scriptdrop, Phil
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Phil
Explore our recently published companies
- Stamey Street - Washington Grove based, 2016 founded, Unfunded company
- Kyle Wachtel - Unfunded company
- Scene OF - Unfunded company
- Hair by Mollie O - United States based, 2008 founded, Unfunded company
- iReward Perk - Singapore based, Unfunded company
- Genesis Consulting - Unfunded company
